Evoq Therapeutics is a cancer immunotherapy company that provides disease-specific immune modulators.
Evoq Therapeutics has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in August 2024.
Evoq Therapeutics's investors include National Institutes of Health.
Evoq Therapeutics is headquartered in Ann Arbor, United States.
Evoq Therapeutics is a cancer immunotherapy company that provides disease-specific immune modulators.
Evoq Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Evoq Therapeutics — Funding & Investors." VCBacked, August 29, 2024, https://www.vcbacked.co/company/evoq-therapeutics. Accessed July 19, 2026.
VCBacked. (2024). Evoq Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/evoq-therapeutics
{{cite web |title=Evoq Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/evoq-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated